NEXLETOL® (bempedoic acid) Tablets Highlighted in EAS 2020 Presentation of Analysis Demonstrating Significant Cholesterol Lowering in People with Familial Hypercholesterolemia

NEXT STORY
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19
PREV STORY
Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ORYZON Reports Results and Corporate Update for Quarter Ended March 31, 2021

author_avatar
NASDAQ Market News

Wake Family Eye Care Offers Patients the New OCULUS Keratograph® 5M for Dry Eye Relief

CARY, N.C., Feb. 05, 2017 (GLOBE NEWSWIRE) -- The new dry eye diagnostic and ...

author_avatar
NASDAQ Market News

Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demonstrating that Crysvita® (burosumab) Improved Outcomes in Children with X-linked Hypophosphatemia in the New England Journal of Medicine

Pediatric Study Demonstrated Improvements in Rickets Severity, Growth, Pain and Physical Activity in Children ...

author_avatar
NASDAQ Market News